| 000 | 01382 a2200361 4500 | ||
|---|---|---|---|
| 005 | 20250517210715.0 | ||
| 264 | 0 | _c20190501 | |
| 008 | 201905s 0 0 eng d | ||
| 022 | _a1664-3224 | ||
| 024 | 7 |
_a10.3389/fimmu.2018.00575 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDornan, Gillian L | |
| 245 | 0 | 0 |
_aMolecular Mechanisms of Human Disease Mediated by Oncogenic and Primary Immunodeficiency Mutations in Class IA Phosphoinositide 3-Kinases. _h[electronic resource] |
| 260 |
_bFrontiers in immunology _c2018 |
||
| 300 |
_a575 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aClass I Phosphatidylinositol 3-Kinases _xgenetics |
| 650 | 0 | 4 |
_aClass Ia Phosphatidylinositol 3-Kinase _xgenetics |
| 650 | 0 | 4 |
_aDevelopmental Disabilities _xetiology |
| 650 | 0 | 4 | _aDisease Susceptibility |
| 650 | 0 | 4 | _aGene Expression Regulation |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunologic Deficiency Syndromes _xetiology |
| 650 | 0 | 4 | _aMutation |
| 650 | 0 | 4 |
_aNeoplasms _xetiology |
| 650 | 0 | 4 | _aOncogenes |
| 650 | 0 | 4 |
_aPhosphatidylinositol 3-Kinases _xgenetics |
| 650 | 0 | 4 | _aSignal Transduction |
| 700 | 1 | _aBurke, John E | |
| 773 | 0 |
_tFrontiers in immunology _gvol. 9 _gp. 575 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.3389/fimmu.2018.00575 _zAvailable from publisher's website |
| 999 |
_c28248935 _d28248935 |
||